Pancrelipase
- Generic Name
- Pancrelipase
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 53608-75-6
- Unique Ingredient Identifier
- FQ3DRG0N5K
- Background
Pancrelipase, in general, is composed of a mixture of pancreatic enzymes which include amylases, lipases, and proteases. These enzymes are extracted from porcine pancreatic glands. The pancrelipase mixture was developed by Ortho-McNeil-Janssen Pharmaceuticals, Inc and FDA approved on April 12, 2010. For further information on the components of this mixture p...
- Indication
The use of pancrelipase amylase is part of the pancreatic enzyme replacement therapy. This therapy is indicated for the treatment of pancreatic insufficiency attributed to cystic fibrosis, chronic pancreatitis or any other medically defined pancreatic disease that might require it. Pancreatic diseases are associated with the deterioration of pancreatic paren...
- Associated Conditions
- Aerophagy, Deficiency Digestive enzymes, Diarrhea, Dyspepsia, Exocrine Pancreatic Insufficiency, Flatulence, Gastrointestinal Discomfort, Pancreatic Insufficiency, Post Operative Gas, Pre-operative Gas, Fat malabsorption, Meteorism
- Associated Therapies
- Bile Duct Disorders, Carbohydrate Digestion, Digestive Aid, Fat Digestion, Liver Metabolism, Protein Digestion
Bioavailability of Pancreatic Enzymes in the Human Upper Intestine (Duodenum and Jejunum)
- Conditions
- Interventions
- First Posted Date
- 2008-09-09
- Last Posted Date
- 2013-02-22
- Lead Sponsor
- Digestive Care, Inc.
- Target Recruit Count
- 11
- Registration Number
- NCT00749099
Intraduodenal Aspiration Study to Assess the Bioavailability of Oral Pancrecarb® Compared to Placebo Control
- Conditions
- Interventions
- First Posted Date
- 2008-08-29
- Last Posted Date
- 2013-02-22
- Lead Sponsor
- Digestive Care, Inc.
- Target Recruit Count
- 3
- Registration Number
- NCT00744250
- Locations
- 🇺🇸
UNC Healthcare, Chapel Hill, North Carolina, United States
Creon 40,000 for Treatment of PEI (Pancreatic Exocrine Insufficiency) Due to Chronic Pancreatitis
- First Posted Date
- 2008-06-27
- Last Posted Date
- 2011-08-18
- Lead Sponsor
- Abbott Products
- Target Recruit Count
- 62
- Registration Number
- NCT00705978
- Locations
- 🇮🇳
Site Reference ID/Investigator# 45390, Chennai, India
🇮🇳Site Reference ID/Investigator# 45391, Hyderabad, India
🇮🇳Site Reference ID/Investigator# 45395, Pune, India
Creon After Pancreatic Surgery
- First Posted Date
- 2007-09-26
- Last Posted Date
- 2011-08-18
- Lead Sponsor
- Abbott Products
- Target Recruit Count
- 58
- Registration Number
- NCT00535756
- Locations
- 🇧🇬
Site Reference ID/Investigator# 45020, Sofia, Bulgaria
🇩🇪Site Reference ID/Investigator# 45024, Munich, Germany
🇮🇹Site Reference ID/Investigator# 45130, Bologna, Italy
Gastrectomy Study: Study to Investigate the Effect of Creon 25000 Minimicrospheres on Body Mass Index (BMI) in Patients After Gastrectomy
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2008-03-31
- Lead Sponsor
- Solvay Pharmaceuticals
- Target Recruit Count
- 40
- Registration Number
- NCT00160186
- Locations
- 🇸🇪
Site 6, Stockholm, Sweden
🇫🇮Site 10, Tampere, Finland
🇩🇰Site 9, Odense, Denmark
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.